info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
United States Flag  US: +1-315-636-4233    United Kingdom Flag  UK: +44-162-237-0614    Indian Flag  IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Blog » transplantation process of cornea experiences

The transplantation process of cornea experiences a new revolutionary change.

Posted On:   Mar-2022   |   Categories : Healthcare

THE REASON BEHIND THE REVOLUTIONARY CHANGE

For a very long time, scientists from all across the world have toiled extremely hard in their field to figure out the various technological advancements that can be done to improvise the process of corneal transplantation. Finally, after a lot of deep analytical research, scientists have successfully been able to bring a revolutionary change in the field of Corneal Transplantation by penetrating the most preferred method of keratoplasty.

 

Some of the most efficient layer-specific corneal surgeries are introduced in the market, like Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK).

Descemet membrane endothelial keratoplasty (DMEK)

DMEK is regarded as a partial-thickness cornea transplant process that mainly involves the selective removal of the patient's endothelium and Descemet membrane, followed by transplantation of Descemet membrane and donor corneal endothelium without the extraction of any sort of additional stromal tissue from the donor.

 

DMEK, by far, is the most advanced form of the process of partial corneal transplant in case of diseases that affect the innermost endothelial layer present in the cornea. In DMEK surgery, only one thin layer of the cell is replaced, thus allowing to form a replica of the anatomical replacements of the cells that are damaged.

 

Read More About Artificial Cornea and Corneal Implant Market Report Here

 

Descemet stripping automated endothelial keratoplasty (DSAEK)

DSAEK is also defined as a partial-thickness cornea transplant process that mainly involves the selective removal of the patient's endothelium and Descemet membrane, followed by the transplantation process of Descemet membrane and donor corneal endothelium but with the extraction of one layer of the stroma from the donor.

 

DSAEK provides a much faster rate of visual recovery. It also reduces the risks of sight-threatening complications to a great extent and lowers the probability of immune rejection of the corneal tissue transplanted.

 

FEW OF THE ESSENTIAL FACTORS PROPELLING THE CORNEAL TRANSPLANTATION MARKET GROWTH ACROSS THE GLOBE:

The Global Corneal Transplantation Market is anticipated to account for up to USD 625.94 million in 2028, with a steady CAGR of 6.13% throughout the estimated frame of time.

 

Some of the factors that are continuously accelerating the rate of market growth are:

a.) The rising prevalence of eyesight-related problems worldwide.

It is one of the pivotal factors that are responsible for augmenting the overall market growth to a great extent. The World Health Organization states that around 2.2 Bn people have a distance or near vision impairment worldwide. Out of which, at least 1 Bn (i.e., 50%) of these cases are yet to be addressed or are left untreated. 

 

b.) The rise in cases of ophthalmic diseases

The continuously increasing cases of ophthalmic diseases such as infectious keratitis, keratoconus, glaucoma & Fuchs dystrophy are also one of the vital factors that are driving the overall growth of the Corneal Transplantation Market extensively. As per Mayo Clinic, glaucoma is one of the leading causes of permanent blindness across the globe. It affects more than 2.7 Mn people who are above age 40 years of age in the United States which constitutes approximately 1.9 % of this population.

 

Moreover, governmental bodies from all across the globe are spending a hefty amount of money towards the various technological advancements for the treatment of corneal diseases, which in turn will lead to ample opportunities for the market in the future.

 

CONCLUSION

After a thorough research process and survey, it was discovered that both DMEK & DSEK had similar favorable five-year survival rates of around 93% when it is performed by the highly experienced surgeons as compared to the survival rates of (19-20) % by keratoplasty. Thus, it will entirely change the concept of the Corneal Transplantation process in the future.

 

Follow us on Twitter Facebook Linkedin Instagram 

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: (+1) 315-636-4233
  • UK: (+44) 1622-370-614
  • IN: (+91) 826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.